Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015656
Filing Date
2025-06-04
Accepted
2025-06-04 18:30:35
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 form4-06042025_100631.html 4  
1 form4-06042025_100631.xml 4 5556
  Complete submission text file 0001415889-25-015656.txt   7022
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
ZASLOFF MICHAEL A (Reporting) CIK: 0001033511 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 251024509

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)